The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
* This Week in the Journal
 August 10, 2006
 Audio Icon Audio Summary
*
Correspondence
* Inhaled Corticosteroids and Children
* Imatinib and Altered Bone and Mineral Metabolism
* Thrombotic Thrombocytopenic Purpura
* Arthrocentesis Video
* Severe Anomaly of Coronary-Artery Development
*
Book Reviews
* Belmont Revisited: Ethical Principles for Research with Human Subjects
* The Mind Has Mountains: Reflections on Society and Psychiatry
* Wrestling with Behavioral Genetics: Science, Ethics, and Public Conversation
* The Ethical Brain
Original Articles
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

In this five-year placebo-controlled trial involving patients who had a recent stroke or transient ischemic attack and baseline low-density lipoprotein cholesterol levels of 100 to 190 mg per deciliter (3 to 5 mmol per liter), atorvastatin (80 mg daily) resulted in an absolute reduction in nonfatal or fatal stroke of 2.2 percent and of major cardiovascular events of 3.5 percent.

Related Editorial


Original Articles
Concordance among Gene-Expression–Based Predictors for Breast Cancer

There are now many published examples of gene-expression–based methods to aid in the determination of prognosis, and some of these methods are available to the clinician. This study of five models shows that four of the five classified cancers concordantly, despite minimal overlap in the gene sets used.

Related Editorial


Original Articles
Determination of Prognosis in Stage IA Non–Small-Cell Lung Cancer

This study showed that a predictor based on gene expression provides prognostic information beyond that provided by traditional clinical predictors. It sets the stage for a prospective trial to determine whether the predictor could be used to guide the treatment of patients with stage IA non–small-cell lung cancer.


Original Articles
Neonatal-Onset Multisystem Inflammatory Disease and Interleukin-1 Blockade

Among patients with neonatal-onset multisystem inflammatory disease — a disorder characterized by fever, urticarial rash, aseptic meningitis, deforming arthropathy, hearing loss, and mental retardation — treatment with the interleukin-1 antagonist anakinra markedly improved clinical and radiologic manifestations of disease (including central nervous system manifestations) and decreased serum markers of inflammation. Anakinra withdrawal resulted in a flare of disease within days; retreatment led to rapid improvement.


Clinical Practice
Paget's Disease of Bone

A 69-year-old man reports increasing pain in the right leg. Physical examination reveals warmth and anterolateral bowing of the right shin. The serum alkaline phosphatase level is 260 U per liter (normal, 38 to 126 U per liter). A skeletal scintigraphic scan reveals enhanced uptake in only the deformed tibia, where a radiograph shows changes indicative of Paget's disease. His sister, whose alkaline phosphatase level is 160 U per liter, has asymptomatic Paget's disease confined to the left iliac wing. How should their cases be managed?


Case Records of the Massachusetts General Hospital
Hypotension after an Overdose of Amlodipine

A 40-year-old woman was transferred to the emergency department of this hospital because of hypotension. Seven hours earlier she had ingested 100 sample tablets of amlodipine (10 mg) in a suicide attempt. She was taken to an emergency department, where her blood pressure fell from 100/60 mm Hg to 58/38 mm Hg despite the use of pressors.


Sounding Board
A Proposal for Radical Changes in the Drug-Approval Process

In this Sounding Board, the author examines potential reasons for the limited availability of new drugs and proposes four solutions to this problem.


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.